Statement of Greg Scandlen Director Center for Consumer Driven Health Care Galen Institute before the Committee on Small Business of the United States House of Representatives Field Hearing On Independent Physicians as Business Owners July 14, 2003 Frederick, Maryland Mr. Chairman and Members of the Committee, Welcome to Frederick. I?m sure Dr. Bartlett has given you … [Read more...] about Independent Physicians as Business Owners
Health Accounts
Grace-Marie has asked me to brief you on two provisions that were added to the House version of the Medicare bill which are designed to empower younger consumers in the health insurance and health care marketplace. I follow these issues closely in Consumer Choice Matters, the companion Galen Institute newsletter that I produce each week and to which you are welcome to subscribe by sending an … [Read more...] about Health Accounts
Health Accounts
Grace-Marie has asked me to brief you on two provisions that were added to the House version of the Medicare bill which are designed to empower younger consumers in the health insurance and health care marketplace. I follow these issues closely in Consumer Choice Matters, the companion Galen Institute newsletter that I produce each week and to which you are welcome to subscribe by sending an … [Read more...] about Health Accounts
You Can Be Above the Law, If You Write It
Value of New Medical Technologies Worth Their Cost
The Joint Economic Committee held a hearing yesterday to examine the link between new health technologies and health care costs. Witnesses included Dr. Mark McClellan, commissioner of the FDA, Dr. Carolyn Clancy of the Agency for Healthcare Research and Quality, Peter Neumann of the Harvard School of Public Health, and Dr. Neil Powe of the Johns Hopkins Medical Center. Senator Robert Bennett, … [Read more...] about Value of New Medical Technologies Worth Their Cost
You Can Be Above the Law, If You Write It
Value of New Medical Technologies Worth Their Cost
The Joint Economic Committee held a hearing yesterday to examine the link between new health technologies and health care costs. Witnesses included Dr. Mark McClellan, commissioner of the FDA, Dr. Carolyn Clancy of the Agency for Healthcare Research and Quality, Peter Neumann of the Harvard School of Public Health, and Dr. Neil Powe of the Johns Hopkins Medical Center. Senator Robert Bennett, … [Read more...] about Value of New Medical Technologies Worth Their Cost